Revenue at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s revenue?
- Collegium Pharmaceutical, Inc. (COLL) reported revenue of $193.52M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s revenue changed year-over-year?
- Collegium Pharmaceutical, Inc.'s revenue increased by 8.9% year-over-year, from $177.76M to $193.52M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s revenue?
- Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s revenue has grown at a 29.6% compound annual growth rate (CAGR), from $276.87M to $780.57M.